Cell Culture Global Market Report 2026

Cell culture involves the growth of human, plant, or animal cells in a laboratory, as well as the cultivation of microorganisms such as bacteria and yeast. These cell cultures can be utilized for research purposes, drug testing, and infection diagnosis. The cells may originate from multicellular eukaryotes, established cell strains, established cell lines, or a combination of these sources.

The main forms of cell culture include primary cell culture, secondary cell culture, and cell line. Primary cell cultures arise from tissue explants or specific cells isolated from the original tissue. The various media can be natural or artificial and are applied in stem cell technologies, cancer research, biopharmaceuticals, tissue engineering, regenerative medicine, and other fields.

Tariffs have increased the cost of imported cell culture reagents, media, and specialized laboratory equipment used in research and biomanufacturing workflows. These impacts are most pronounced in North America and Europe, where laboratories depend heavily on global life science supply networks. Rising tariff related expenses have placed pressure on research budgets and operational planning. This has influenced purchasing decisions and slowed expansion of cell based research activities in some settings. However, tariffs are also driving domestic production of laboratory consumables, local supplier development, and stronger regional life science manufacturing ecosystems over the long term.

The cell culture market research report is one of a series of new reports from The Business Research Company that provides cell culture market statistics, including cell culture industry global market size, regional shares, competitors with a cell culture market share, detailed cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture industry. This cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell culture market size has grown strongly in recent years. It will grow from $31.25 billion in 2025 to $33.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to growth in life science research, increased academic funding, expansion of biopharmaceutical industry, widespread use of cell lines, demand for in vitro testing.

The cell culture market size is expected to see strong growth in the next few years. It will grow to $46.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growth in regenerative medicine, increasing biologics development, innovation in cell culture media, expansion of personalized medicine, rising r&d investments. Major trends in the forecast period include rising demand for biopharmaceutical production, growth in stem cell research, expansion of cancer research applications, increasing adoption of advanced cell lines, focus on serum-free media usage.

The increasing demand for personalized medicine is anticipated to drive the growth of the cell culture market in the coming years. Personalized medicines, also referred to as precision medicine, are medical treatments and therapies designed to match the specific characteristics of individual patients. The rising demand for personalized medicine stems from patients seeking healthcare customized to their unique genetic, molecular, and environmental profiles, resulting in better treatment outcomes and fewer side effects. Cell culture is essential in personalized medicine, serving as a key tool for research, drug development, disease modeling, and therapeutic applications tailored to individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization advocating for individualized treatment approaches, reported that 20 of the 53 new therapeutic molecular entities approved by the Food and Drug Administration in 2023, along with six new gene and cell-based therapies, were classified as personalized medicines, representing roughly 38% of all new molecular entities approved in the country. Consequently, the growing demand for personalized medicine is fueling the expansion of the cell culture market.

Major companies operating in the cell culture market are focusing on developing innovative cell culture solutions, such as the cQrex portfolio, to enhance the efficiency and productivity of cell cultures and tackle the challenges associated with them. The cQrex portfolio of cell culture ingredients is designed to boost efficiency and productivity. This portfolio consists of a suite of peptides and the keto acid AKG, which aim to manage the supply of essential nutrients by improving their stability or solubility, thereby increasing productivity. For example, in June 2023, Evonik Industries AG, a Germany-based specialty chemicals company, introduced the cQrex portfolio of cell culture ingredients to enhance efficiency and productivity. It serves as a valuable resource for cell culture scientists seeking to optimize the efficiency and productivity of their cell cultures. It is particularly beneficial for cultures used to produce high-value products, such as monoclonal antibodies and vaccines. These ingredients are favored for their high purity, broad applicability, and ease of use. Additionally, they assist cell culture scientists in improving the efficiency and productivity of their cell cultures.

In September 2025, Fluidic Sciences, a US-based life sciences technology company, acquired the business and assets of Sphere Bio for an undisclosed amount. Through this acquisition, Fluidic Sciences intends to strengthen its single-cell analysis and protein interaction discovery capabilities by incorporating Sphere Bio's proprietary cell-based assays and high-throughput screening technologies, facilitating accelerated research in cellular biology and therapeutic development. Sphere Bio, a US-based biotechnology company, specializes in cell-based assays and protein interaction platforms, with a strong history of supporting single-cell and molecular discovery applications.

Major companies operating in the cell culture market are Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Lonza Group, HiMedia Laboratories, Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, InvivoGen, Greiner Bio-One, Irvine Scientific, Cell Culture Company (CCC) LLC, Sera Care Life Sciences Incorporation, American Type Culture Collection, Miltenyi Biotec, Bel-Art Products Inc., Sumitomo Bakelite, EMD Millipore, VWR International LLC, WHEATON IndustriesInc, Sartorius AG, Nunc Systems, Pall Corporation

North America was the largest region in the cell culture market in 2025. The Middle East is expected to be the fastest-growing region in the global cell culture market share during the forecast period. The regions covered in the cell culture market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell culture market includes revenues earned by entities by diagnosing infections, testing new drugs, and conducting research. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Culture Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Primary Cell Culture; Secondary Cell Culture; Cell Line
• 2) By Media: Natural; Artificial
• 3) By Applications: Stem Cell Technologies; Cancer Research; Biopharmaceutical; Tissue Engineering & Regenerative Medicine; Other Applications
• Subsegments:
• 1) By Primary Cell Culture: Adherent Cell Culture; Suspension Cell Culture
• 2) By Secondary Cell Culture: Continuous Cell Lines; Finite Cell Lines
• 3) By Cell Line: Immortalized Cell Lines; Transformed Cell Lines
• Companies Mentioned: Becton Dickinson; Corning Incorporation; Eppendorf; GE Healthcare; Merck KGaA; Thermo Fisher Scientific; Lonza Group; HiMedia Laboratories; Agilent Technologies Inc.; PromoCell GmbH; CellGenix GmbH; InvivoGen; Greiner Bio-One; Irvine Scientific; Cell Culture Company (CCC) LLC; Sera Care Life Sciences Incorporation; American Type Culture Collection; Miltenyi Biotec; Bel-Art Products Inc.; Sumitomo Bakelite; EMD Millipore; VWR International LLC; WHEATON IndustriesInc; Sartorius AG; Nunc Systems; Pall Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.